Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.

Saved in:
Bibliographic Details
Title: Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy.
Authors: Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic, Jacksonville, Florida. Electronic address: KharfanDabaja.Mohamed@mayo.edu., Kumar A; Program for Comparative Effectiveness Research, Morsani College of Medicine, University of South Florida, Tampa, Florida., Ayala E; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapies Program, Mayo Clinic, Jacksonville, Florida., Aljurf M; Department of Adult Hematology and Stem Cell Transplantation, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia., Nishihori T; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., Marsh R; Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio., Burroughs LM; Fred Hutchinson Cancer Research Center, Seattle, Washington., Majhail N; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Al-Homsi AS; NYU Langone Health, New York, New York., Al-Kadhimi ZS; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska., Bar M; Fred Hutchinson Cancer Research Center, Seattle, Washington., Bertaina A; Division of Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California., Boelens JJ; Stem Cell Transplantation and Cellular Therapies Program, Department Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chaudhury S; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois., DeFilipp Z; Department of Hematology-Oncology and Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, Massachusetts., Dholaria B; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., El-Jawahri A; Department of Hematology-Oncology and Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, Massachusetts., Fanning S; Blood and Marrow Transplant Program, University of South Carolina School of Medicine, Greenville, South Carolina., Fraint E; Stem Cell Transplantation and Cellular Therapies Program, Department Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Gergis U; Bone Marrow Transplant and Immune Cellular Therapy, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Giralt S; Department of Medicine, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center Weill Cornell Medical College, New York, New York., Hamilton BK; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Hashmi SK; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates., Horn B; Department of Pediatrics, Division of Hematology/Oncology, University of Florida, UF Health Shands Children's Hospital, Gainesville, Florida., Inamoto Y; Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan., Jacobsohn DA; Division of Blood and Marrow Transplantation Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC., Jain T; Hematologic Malignancies and Bone Marrow Transplantation Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland., Johnston L; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, Stanford, California., Kanate AS; West Virginia University, Morgantown, West Virginia., Kansagra A; UT Southwestern Medical Center, Dallas, Texas., Kassim A; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Kean LS; Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts., Kitko CL; Division of Pediatric Hematology/Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Knight-Perry J; Department of Pediatrics, Division of Hematology/Oncology/BMT, University of Colorado School of Medicine, Aurora, Colorado., Kurtzberg J; Pediatric Blood and Marrow Transplant Program, Duke University School of Medicine, Durham, North Carolina., Liu H; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida., MacMillan ML; Blood and Marrow Transplant Program, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, Minneapolis., Mahmoudjafari Z; Division of Pharmacy, University of Kansas Cancer Center, University of Kansas Health System, Lawrence, Kansas., Mielcarek M; Fred Hutchinson Cancer Research Center, Seattle, Washington., Mohty M; Sorbonne Université, INSERM, Centre de Recherche Saint-Antoine and Hôpital Saint-Antoine, Service d'Hématologie Clinique et Thérapie Cellulaire, Paris, France., Nagler A; Chaim Sheba Medical Center, Tel Hashomer, Israel., Nemecek E; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon., Olson TS; Blood and Marrow Transplant Section, Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Pennsylvania., Oran B; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Perales MA; Department of Medicine, Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center Weill Cornell Medical College, New York, New York., Prockop SE; Stem Cell Transplantation and Cellular Therapies Program, Department Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Pulsipher MA; Children's Hospital Los Angeles Cancer and Blood Disease Institute, USC Keck School of Medicine, Los Angeles, California., Pusic I; Division of Oncology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri., Riches ML; Division of Hematology, University of North Carolina at Chapel Hill, North Carolina., Rodriguez C; Department of Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, North Carolina., Romee R; Cellular Therapy and Stem Cell Transplant Program, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Rondon G; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas., Saad A; Division of Hematology, The Ohio State University, Columbus, Ohio., Shah N; Division of Hematology-Oncology, Department of Medicine, University of California San Francisco, San Francisco, California., Shaw PJ; The Children's Hospital at Westmead, Sydney, Australia., Shenoy S; Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri., Sierra J; Department of Hematology, Hospital de la Santa Creu i Sant Pau, Josep Carreras Leukemia Research Institute, Barcelona, Spain., Talano J; Department of Pediatric Hematology/Oncology, Children's Hospital of Wisconsin, Medical College of Wisconsin, Milwaukee, Wisconsin., Verneris MR; Department of Pediatrics, Division of Hematology/Oncology/BMT, University of Colorado School of Medicine, Aurora, Colorado., Veys P; Blood & Marrow Transplant Unit, Great Ormond Street Hospital, University College London, London, United Kingdom., Wagner JE; Blood and Marrow Transplant Program, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, Minneapolis., Savani BN; Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee., Hamadani M; Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin., Carpenter PA; Fred Hutchinson Cancer Research Center, Seattle, Washington.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2021 Aug; Vol. 27 (8), pp. 642-649.
Publication Type: Practice Guideline; Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6367
DOI:10.1016/j.jtct.2021.04.007